Menu Back to Digital-Technology-in-Clinical-Trials

Overview

Digital technology is transforming the drug development process. The rise of wearable and mobile technologies along with cloud technology, Artificial Intelligence and related platforms, now enable the collection of frequent, specific, and multidimensional data throughout the length of trials. These technologies have the potential to enable innovative trial designs, improve the patient experience, act as recruitment and retention tools, and establish novel end points in clinical studies.

With these technologies, large amounts of data are collected. How to best address evaluating fit-for-purpose, standardization, ethical concerns, and regulatory approaches, are key issues to address in the digital era.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for implementing digital technology to improve clinical trials. While the conference will focus on the impact of digitalization in clinical trials today, we will make time to explore future applications and how they may enable the clinical trials of tomorrow.

Co-Sponsored with Critical Path Institute’s ePRO Consortium

Who should attend?

Executive, Leadership, and Management Professionals from Biotechnology, Pharmaceutical, Device, CRO, Regulatory Agency, and Academic Research Sponsors involved in:

  • Business Development
  • Clinical Trial Design and Development
  • Study Endpoint Development
  • Clinical Research, Operations, Site Selection, and Management
  • Research and Development
  • Clinical Monitoring and Oversight
  • Quality Management
  • Contracts Management
  • Clinical Data Management
  • Data and Biostatistical Sciences
  • Health Economics and Outcomes Research
  • eClinical Technology and Solutions
  • Digital Strategies and Technologies
  • Data Analytics, Strategy, and Technology
  • Information Technology, Systems, and Programming
  • Regulatory Affairs
  • Patient Engagement, Recruitment, and Retention
  • Patient Advocacy, Partnerships, and Services
  • Legal and Compliance
  • Ethics, IRBs
  • Medical Affairs and Communications

Program Committee

  • Sonya  Eremenco, MA
    Sonya Eremenco, MA Director, PRO Consortium
    Critical Path Institute, United States
  • Jennifer  Goldsack, MA, MBA, MS
    Jennifer Goldsack, MA, MBA, MS Executive Director
    Digital Medicine Society (DiMe), United States
  • Erin  Iturriaga, MSN
    Erin Iturriaga, MSN Clinical Trials Specialist
    National Heart, Lung, and Blood Institute (NHLBI), United States
  • Jonathan Raymond Andrus, MS
    Jonathan Raymond Andrus, MS Chief Business Officer
    Clinical Ink, United States
  • Lindsay Stiles Kehoe, MS
    Lindsay Stiles Kehoe, MS Project Manager
    Clinical Trials Transformation Initiative (CTTI), United States
  • Bill  Byrom, PhD
    Bill Byrom, PhD Vice President, Product Intelligence and Positioning
    Signant Health , United Kingdom
  • Megan  Doyle, JD, MPH
    Megan Doyle, JD, MPH Global Policy Lead, Digital Health, Diagnostics, and Combination Products
    Amgen, United States
  • Estelle  Haenel, DrSc, PharmD
    Estelle Haenel, DrSc, PharmD Medical Director
    Kayentis, France
  • Elena  Izmailova, PhD
    Elena Izmailova, PhD CSO
    Koneksa, United States
  • Jules T Mitchel, MBA, PhD
    Jules T Mitchel, MBA, PhD Principal Consultant
    THI Pharma Services, United States
  • Paul  O'Donohoe, MS, MSc
    Paul O'Donohoe, MS, MSc Senior Director, eCOA Product and Science
    Medidata Solutions, United States
  • Lauren  Oliva, PharmD, RPh
    Lauren Oliva, PharmD, RPh Global Regulatory Policy Lead, New Technologies
    Biogen, United States
  • Paul  Upham
    Paul Upham Head, Smart Devices
    Roche / Genentech, United States
  • Keith  Wenzel
    Keith Wenzel Senior Director, Scientific Data Organization
    Parexel International, United States
  • Anindita  Saha
    Anindita Saha Assistant Director, Digital Health Center of Excellence, CDRH
    FDA, United States
  • Prem  Sreenivasan
    Prem Sreenivasan Associate Director
    Colgate-Palmolive Company, United States
Load More